[ad_1]
Xencor (NASDAQ:XNCR – Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.78) by $0.37. The business had revenue of $43.61 million for the quarter, compared to analyst estimates of $22.59 million. Xencor had a negative return on equity of 25.75% and a negative net margin of 121.52%. The business’s revenue was up 82.4% compared to the same quarter last year. During the same quarter last year, the firm posted ($1.07) earnings per share.
[ad_2]
Source link
Xencor (NASDAQ:XNCR) Releases Earnings Results, Beats Expectations By $0.37 EPS
